2024-09-01 2025-08-31 2025-08-31 false 10338290 DR WOODSIDE FACIAL AESTHETICS LIMITED 2026-02-02 false iso4217:GBP xbrli:pure 10338290 2024-08-31 10338290 2025-08-31 10338290 2024-09-01 2025-08-31 10338290 2023-08-31 10338290 2024-08-31 10338290 2023-09-01 2024-08-31 10338290 bus:SmallEntities 2024-09-01 2025-08-31 10338290 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 10338290 bus:FullAccounts 2024-09-01 2025-08-31 10338290 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 10338290 core:WithinOneYear 2025-08-31 10338290 core:AfterOneYear 2025-08-31 10338290 core:WithinOneYear 2024-08-31 10338290 core:AfterOneYear 2024-08-31 10338290 core:ShareCapital 2025-08-31 10338290 core:SharePremium 2025-08-31 10338290 core:RevaluationReserve 2025-08-31 10338290 core:OtherReservesSubtotal 2025-08-31 10338290 core:RetainedEarningsAccumulatedLosses 2025-08-31 10338290 core:ShareCapital 2024-08-31 10338290 core:SharePremium 2024-08-31 10338290 core:RevaluationReserve 2024-08-31 10338290 core:OtherReservesSubtotal 2024-08-31 10338290 core:RetainedEarningsAccumulatedLosses 2024-08-31 10338290 core:LandBuildings 2025-08-31 10338290 core:PlantMachinery 2025-08-31 10338290 core:Vehicles 2025-08-31 10338290 core:FurnitureFittings 2025-08-31 10338290 core:OfficeEquipment 2025-08-31 10338290 core:NetGoodwill 2025-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 10338290 core:ListedExchangeTraded 2025-08-31 10338290 core:UnlistedNon-exchangeTraded 2025-08-31 10338290 core:LandBuildings 2024-08-31 10338290 core:PlantMachinery 2024-08-31 10338290 core:Vehicles 2024-08-31 10338290 core:FurnitureFittings 2024-08-31 10338290 core:OfficeEquipment 2024-08-31 10338290 core:NetGoodwill 2024-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 10338290 core:ListedExchangeTraded 2024-08-31 10338290 core:UnlistedNon-exchangeTraded 2024-08-31 10338290 core:LandBuildings 2024-09-01 2025-08-31 10338290 core:PlantMachinery 2024-09-01 2025-08-31 10338290 core:Vehicles 2024-09-01 2025-08-31 10338290 core:FurnitureFittings 2024-09-01 2025-08-31 10338290 core:OfficeEquipment 2024-09-01 2025-08-31 10338290 core:NetGoodwill 2024-09-01 2025-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 10338290 core:ListedExchangeTraded 2024-09-01 2025-08-31 10338290 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10338290 core:MoreThanFiveYears 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments 2025-08-31 10338290 core:Non-currentFinancialInstruments 2024-08-31 10338290 dpl:CostSales 2024-09-01 2025-08-31 10338290 dpl:DistributionCosts 2024-09-01 2025-08-31 10338290 core:LandBuildings 2024-09-01 2025-08-31 10338290 core:PlantMachinery 2024-09-01 2025-08-31 10338290 core:Vehicles 2024-09-01 2025-08-31 10338290 core:FurnitureFittings 2024-09-01 2025-08-31 10338290 core:OfficeEquipment 2024-09-01 2025-08-31 10338290 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 10338290 core:NetGoodwill 2024-09-01 2025-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 10338290 dpl:GroupUndertakings 2024-09-01 2025-08-31 10338290 dpl:ParticipatingInterests 2024-09-01 2025-08-31 10338290 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-01 2025-08-31 10338290 core:ListedExchangeTraded 2024-09-01 2025-08-31 10338290 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10338290 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 10338290 dpl:CostSales 2023-09-01 2024-08-31 10338290 dpl:DistributionCosts 2023-09-01 2024-08-31 10338290 core:LandBuildings 2023-09-01 2024-08-31 10338290 core:PlantMachinery 2023-09-01 2024-08-31 10338290 core:Vehicles 2023-09-01 2024-08-31 10338290 core:FurnitureFittings 2023-09-01 2024-08-31 10338290 core:OfficeEquipment 2023-09-01 2024-08-31 10338290 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 10338290 core:NetGoodwill 2023-09-01 2024-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 10338290 dpl:GroupUndertakings 2023-09-01 2024-08-31 10338290 dpl:ParticipatingInterests 2023-09-01 2024-08-31 10338290 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-31 10338290 core:ListedExchangeTraded 2023-09-01 2024-08-31 10338290 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 10338290 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 10338290 core:NetGoodwill 2025-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 10338290 core:LandBuildings 2025-08-31 10338290 core:PlantMachinery 2025-08-31 10338290 core:Vehicles 2025-08-31 10338290 core:FurnitureFittings 2025-08-31 10338290 core:OfficeEquipment 2025-08-31 10338290 core:AfterOneYear 2025-08-31 10338290 core:WithinOneYear 2025-08-31 10338290 core:ListedExchangeTraded 2025-08-31 10338290 core:UnlistedNon-exchangeTraded 2025-08-31 10338290 core:ShareCapital 2025-08-31 10338290 core:SharePremium 2025-08-31 10338290 core:RevaluationReserve 2025-08-31 10338290 core:OtherReservesSubtotal 2025-08-31 10338290 core:RetainedEarningsAccumulatedLosses 2025-08-31 10338290 core:NetGoodwill 2024-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 10338290 core:LandBuildings 2024-08-31 10338290 core:PlantMachinery 2024-08-31 10338290 core:Vehicles 2024-08-31 10338290 core:FurnitureFittings 2024-08-31 10338290 core:OfficeEquipment 2024-08-31 10338290 core:AfterOneYear 2024-08-31 10338290 core:WithinOneYear 2024-08-31 10338290 core:ListedExchangeTraded 2024-08-31 10338290 core:UnlistedNon-exchangeTraded 2024-08-31 10338290 core:ShareCapital 2024-08-31 10338290 core:SharePremium 2024-08-31 10338290 core:RevaluationReserve 2024-08-31 10338290 core:OtherReservesSubtotal 2024-08-31 10338290 core:RetainedEarningsAccumulatedLosses 2024-08-31 10338290 core:NetGoodwill 2023-08-31 10338290 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 10338290 core:LandBuildings 2023-08-31 10338290 core:PlantMachinery 2023-08-31 10338290 core:Vehicles 2023-08-31 10338290 core:FurnitureFittings 2023-08-31 10338290 core:OfficeEquipment 2023-08-31 10338290 core:AfterOneYear 2023-08-31 10338290 core:WithinOneYear 2023-08-31 10338290 core:ListedExchangeTraded 2023-08-31 10338290 core:UnlistedNon-exchangeTraded 2023-08-31 10338290 core:ShareCapital 2023-08-31 10338290 core:SharePremium 2023-08-31 10338290 core:RevaluationReserve 2023-08-31 10338290 core:OtherReservesSubtotal 2023-08-31 10338290 core:RetainedEarningsAccumulatedLosses 2023-08-31 10338290 core:AfterOneYear 2024-09-01 2025-08-31 10338290 core:WithinOneYear 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:CostValuation 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 10338290 core:Non-currentFinancialInstruments core:CostValuation 2025-08-31 10338290 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-31 10338290 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 10338290 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 10338290 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 10338290 bus:Director1 2024-09-01 2025-08-31

DR WOODSIDE FACIAL AESTHETICS LIMITED

Registered Number
10338290
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

DR WOODSIDE FACIAL AESTHETICS LIMITED
Company Information
for the year from 1 September 2024 to 31 August 2025

Director | Dr Lucy Woodside

Registered Address | 1 Heslington Lane Fulford Lodge
| Fulford
| York
| YO10 4HW

Registered Number | 10338290 (England and Wales)

DR WOODSIDE FACIAL AESTHETICS LIMITED
Statement of Financial Position
31 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 58 |  |  |  | 77
|  |  |  | 58 |  |  |  | 77
Current assets |  |  |  |  |  |  |  |
Stocks | 4 | 5,454 |  |  |  | 5,720 |  |
Debtors | 5 | 382 |  |  |  | 384 |  |
Cash at bank and on hand |  | 8,064 |  |  |  | 9,126 |  |
|  | 13,900 |  |  |  | 15,230 |  |
Creditors amounts falling due within one year | 6 | (782) |  |  |  | (6,746) |  |
Net current assets (liabilities) |  |  |  | 13,118 |  |  |  | 8,484
Total assets less current liabilities |  |  |  | 13,176 |  |  |  | 8,561
Net assets |  |  |  | 13,176 |  |  |  | 8,561
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 13,076 |  |  |  | 8,461
Shareholders' funds |  |  |  | 13,176 |  |  |  | 8,561

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 2 February 2026, and are signed on its behalf by:
Dr Lucy Woodside Director Registered Company No. 10338290

DR WOODSIDE FACIAL AESTHETICS LIMITED
Notes to the Financial Statements
for the year ended 31 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.

| Basis of preparation
--- | ---
| The financial statements have been prepared on the historical cost basis.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling, which is the functional currency of the entity.

| Going concern
--- | ---
| The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.

| Turnover policy
--- | ---
| The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

| Current taxation
--- | ---
| The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.

| Tangible fixed assets and depreciation
--- | ---
| Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Stocks and work in progress
--- | ---
| Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.

| Financial instruments
--- | ---
| A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

| Related parties
--- | ---
| For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 1

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| At 01 September 24 | 578 |  | 578
| At 31 August 25 | 578 |  | 578
| Depreciation and impairment
| At 01 September 24 | 501 |  | 501
| Charge for year | 19 |  | 19
| At 31 August 25 | 520 |  | 520
| Net book value
| At 31 August 25 | 58 |  | 58
| At 31 August 24 | 77 |  | 77

4. | Stocks
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other stocks | 5,454 |  | 5,720
| Total | 5,454 |  | 5,720

5. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Prepayments and accrued income | 382 |  | 384
| Total | 382 |  | 384

6. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Amounts owed to related parties | 250 |  | 6,531
| Other creditors | - |  | 36
| Accrued liabilities and deferred income | 532 |  | 179
| Total | 782 |  | 6,746

7. | Related party transactions
--- | ---
| At the year end the company owed the director £250 (2024: £6,531). This balance is included within creditors. This loan is interest free and repayable on demand.